Simultaneous regression of non‐small cell lung cancer and orbital extranodal marginal zone lymphoma with chemoradiotherapy for lung cancer

• Published in: Respirology case reports Vol. 11; no. 7; pp. e01171 - n/a
• Main Authors: Oi, Issei, Saito, Zentaro, Ito, Takanori, Imakita, Takuma, Kanai, Osamu, Fujita, Kohei, Tachibana, Hiromasa, Mori, Minako, Morioshi, Koki, Mio, Tadashi
• Format: Journal Article
• Language: English
• Published: Chichester, UK John Wiley & Sons, Ltd 01.07.2023; John Wiley & Sons, Inc; Wiley
• Subjects: Biopsy; Cancer therapies; Case Report; Case Reports; Chemotherapy; extra marginal zone lymphoma; Lung cancer; Lymphoma; Magnetic resonance imaging; orbital lymphoma; Radiation therapy; Tomography; Japan; lung cancer; orbital lymphoma; chemotherapy; extra marginal zone lymphoma
• ISSN: 2051-3380; 2051-3380
• DOI: 10.1002/rcr2.1171

This report describes the case of a 79‐year‐old Japanese man diagnosed with orbital extranodal marginal zone lymphoma (EMZL) and stage IIIA lung cancer. The patient received concurrent chemoradiation for lung cancer with carboplatin/paclitaxel treatment, resulting in regression of both the lymphoma and lung cancer. To our knowledge, this is the first reported case of concurrent orbital EMZL and lung cancer. In this case, a treatment strategy that prioritized lung cancer treatment was deemed appropriate. This case suggests that chemotherapy with carboplatin and paclitaxel may serve as an effective treatment for both lung cancer and lymphoma. This report describes the case of a 79‐year‐old Japanese man diagnosed with orbital extranodal marginal zone lymphoma (EMZL) and stage IIIA lung cancer. The patient received concurrent chemoradiation for lung cancer with carboplatin/paclitaxel treatment, resulting in regression of both the lymphoma and lung cancer.